Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma

Published:2002-01 Issue:1 Volume:131 Page:S148-S152
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Adachi Eisuke,Maehara Shin-ichiro,Tsujita Eiji,Taguchi Ken-ichi,Aishima Shin-ichi,Rikimaru Tatsuya,Yamashita Yo-ichi,Tanaka Shinji

Publisher

Elsevier BV

Subject

Surgery

Reference26 articles.

1. Diagnosis and follow-up of small hepatocellular carcinoma with selective intraarterial digital subtraction angiography;Ikeda;Hepatology,1993

2. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma;Oka;Hepatology,1994

3. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection;Castells;Hepatology,1993

4. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection;Jwo;Hepatology,1992

5. Incidence and risk factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma;Nagasue;Gastroenterology,1993

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Constructing a Predictive Model for Pancreatic Cancer Postoperative Recurrence: Based on the SEER Database;Advances in Clinical Medicine;2024

2. The appropriate method of hepatectomy for hepatocellular carcinoma within University of California San Francisco (UCSF) criteria through neural network analysis;HPB;2023-05

3. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort;Frontiers in Endocrinology;2023-01-31

4. DJ-1/FGFR-1 Signaling Pathway Contributes to Sorafenib Resistance in Hepatocellular Carcinoma;Oxidative Medicine and Cellular Longevity;2022-06-20

5. “Logic-Based Medicine” Is More Feasible than “Evidence-Based Medicine” in the Local Treatment for Hepatocellular Carcinoma;Oncology;2020